Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Han

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Heart (British Cardiac Society)|February 13, 2015
Does TCPC power loss really affect exercise capacity?Reza H Khiabani, Kevin K Whitehead, David Han, et al.
British Journal of Clinical Pharmacology|June 2, 2022
AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT intervalDinko Rekić, Ivan Azarov, Jane Knöchel, et al.
Plos One|July 23, 2013
Long term Suboxone™ emotional reactivity as measured by automatic detection in speechEdward Hill, David Han, Pierre Dumouchel, et al.
Plos One|August 6, 2015
Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired PatientsEric R Braverman, Kenneth Blum, Karl L Hussman, et al.
Nature Communications|September 25, 2010
Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperoneBei Liu, Yi Yang, Zhijuan Qiu, et al.
Current Psychiatry Research and Reviews|September 19, 2022
Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty CasesKenneth Blum, David Han, David Baron, et al.
Asian Journal of Complementary and Alternative Medicine : A-CAM|March 3, 2023
Reward Deficiency Syndrome Solution System (RDSSS) A Genetically Driven Putative Inducer of "Dopamine Homeostasis" as a Futuristic Alternative to Enhance Rehabilitation Instead of IncarcerationKenneth Blum, Richard Green, Paul Mullen, et al.
Research Square|March 16, 2026
First‑Day Glycemic Exposure and 28‑Day Mortality in the ICU: A Multicenter Cohort StudyJoab O Odera, Betsabe Blas, Julie Cha, et al.
Plos One|January 6, 2017
Mapping the Interactome of a Major Mammalian Endoplasmic Reticulum Heat Shock Protein 90Feng Hong, Saleh Mohammad Rachidi, Debbie Lundgren, et al.
Clinical and Translational Science|August 10, 2020
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection FractionKarin Nelander, Maria Lagerstrom-Fermer, Carl Amilon, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Heart (British Cardiac Society)|February 13, 2015
Does TCPC power loss really affect exercise capacity?Reza H Khiabani, Kevin K Whitehead, David Han, et al.
British Journal of Clinical Pharmacology|June 2, 2022
AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT intervalDinko Rekić, Ivan Azarov, Jane Knöchel, et al.
Plos One|July 23, 2013
Long term Suboxone™ emotional reactivity as measured by automatic detection in speechEdward Hill, David Han, Pierre Dumouchel, et al.
Plos One|August 6, 2015
Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired PatientsEric R Braverman, Kenneth Blum, Karl L Hussman, et al.
Nature Communications|September 25, 2010
Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperoneBei Liu, Yi Yang, Zhijuan Qiu, et al.
Current Psychiatry Research and Reviews|September 19, 2022
Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty CasesKenneth Blum, David Han, David Baron, et al.
Asian Journal of Complementary and Alternative Medicine : A-CAM|March 3, 2023
Reward Deficiency Syndrome Solution System (RDSSS) A Genetically Driven Putative Inducer of "Dopamine Homeostasis" as a Futuristic Alternative to Enhance Rehabilitation Instead of IncarcerationKenneth Blum, Richard Green, Paul Mullen, et al.
Research Square|March 16, 2026
First‑Day Glycemic Exposure and 28‑Day Mortality in the ICU: A Multicenter Cohort StudyJoab O Odera, Betsabe Blas, Julie Cha, et al.
Plos One|January 6, 2017
Mapping the Interactome of a Major Mammalian Endoplasmic Reticulum Heat Shock Protein 90Feng Hong, Saleh Mohammad Rachidi, Debbie Lundgren, et al.
Clinical and Translational Science|August 10, 2020
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection FractionKarin Nelander, Maria Lagerstrom-Fermer, Carl Amilon, et al.
Pageof 11